A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia

Clinical and Experimental Immunology

Volumn 114, Issue 2, 1998, Pages 277-283

  Larsson, P ^a,c   Mattsson, L ^a   Klareskog, L ^a   Johnsson, C ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Analogue; Arthritis; Experimental; Hypercalcaemia; Immunomo dulation; Treatment; Vitamin D3

Indexed keywords

COLLAGEN TYPE 2; IMMUNOMODULATING AGENT; LEXACALCITOL; MITOGENIC AGENT; PROPYLENE GLYCOL; VITAMIN D DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTHRITIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HYPERCALCEMIA; IMMUNIZATION; IMMUNOMODULATION; LYMPH NODE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ARTHRITIS, RHEUMATOID; CALCITRIOL; COLLAGEN; DOWN-REGULATION; FEMALE; HYPERCALCEMIA; LYMPH NODES; MITOGENS; RATS; TIME FACTORS; TITRIMETRY;

EID: 0031791746     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00706.x     Document Type: Article

References (30)

1. Vieth K. The mechanism of vitamin D toxicity. Bone 1990; 11:267-72.
2. Brown AJ, Dusso A, Slatopolsky E. Selective vitamin D analogs and their therapeutic applications. Sem Nephrol 1994; 14:156-74.
3. Casteels K, Bouillon R, Waer M, Mathieu C. Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Current Op Nephrol Hyperten 1995; 4:313-8.
4. 3 in human peripheral blood mononuclear cells presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983; 57:1308-10.
5. 3 receptors in human leukocytes. Science 1983; 221:1181-3.
6. 3 (calcitriol). J Clin Invest 1984; 74:1451-5.
7. 3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134:3032-5.
8. 3 inhibits γ-interferon synthesis by normal human peripheral bloond lymphocytes. Proc Natl Acad Sci USA 1987; 84:3385-4.
9. 3. Specitic inhibition at the level of messenger RNA. J Clin Invest 1987; 79:654-64.
10. 3 in normal human peripheral blood monocytes. J Clin Invest 1987; 79:1700-5.
11. Johnsson C, Binderup L, Tufveson G. The effects of combined treatment with the novel vitamin D analogue MC 1288 and cyclosporine A on cardiac allograft survival. Transpl Immunol 1995; 3:245-50.
12. Johnsson C, Binderup L, Tufveson G. Immunosuppression with the vitamin D analogue MC 1288 in experimental transplantation. Transpl Proc 1996; 28:888-91.
13. Lemire JM, Archer DC, Beck L et al. The role and mechanism of vitamin D analogs in immune-suppression. In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D. A pluripotent steroid hormone: structural studies, molecular endocrinology and clinical application. Berlin: Walter de Gruyter, 1994:531-4.
14. 3 prevents in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991; 87:1103-7.
15. Fournier C, Gepner P, Sadouk M, Charreire J. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1990; 54:53-63.
16. 3 and its analogues. In: Norman AW, Bouillon R, Thomasset M, Vitamin D, eds. A pluripotent steroid hormone: structural studies, molecular endocrinology and clinical application. Berlin: Walter de Gruyter. 1994:540.
17. Larsson P, Kleinau S, Holmdahl R, Klareskog L. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats alter immunization with the same collagen preparation. Arthritis Rheum 1990; 33:693-701.
18. Klareskog L, Holmdahl R, Larsson E, Wigzell H. Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Med 1985; 51:117-25.
19. Ranges GE, Srinam S, Cooper SM. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 1985; 162:1105-10.
20. Müssener Å, Klareskog L, Lorentzen JC, Kleinau S. TNF-α dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis. Scand J Immunol 1995; 42:128-34.
21. Mattsson L, Lorentzen JC, Svelander L et al. The adjuvant alum used in conjunction with collagen type II suppresses the development of collagen induced arthritis in rats by skewing the immune response. Scand J Immunol 1997; 46:619-24.
22. Miller EJ. Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 1972; 11:4403-9.
23. Johnssou C, Binderup L, Tufveson G, Vitamin D analogues for immunosuppression: a comparison between various routes of administration. Transpl Proc 1995; 27:3538-4.
24. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence of an immunological involvement. J Autoimmun 1991; 4:871-80.
25. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 1991; 42:1569-75.
26. 3. J Steroid Biochem Molec Biol 1995; 53:599-602.
27. Müssener Å, Lorentzen JC, Kleinau S, Klareskog L. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains. Eur J Immunol 1997; 27:695-9.
28. Joosten LA, Lubberts E, Durez P et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997; 40:249-60.
29. Bessis N, Boissier MC, Ferranrai P et al. Attenuation of collagen-induced arthritis in mice by treatment of vector cells engineered to secrete interleukin-13. Eur J Immunol 1996; 26:2399-403.
30. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998; 128:68-72.